The Need for New Drugs against Tuberculosis
Authors:
- 1 April 2001
- journal article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 163 (5) , 1055-1058
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Use of genomics and combinatorial chemistry in the development of new antimycobacterial drugsBiochemical Pharmacology, 2000
- Global Burden of TuberculosisJAMA, 1999
- Measurement of Sputum Mycobacterium tuberculosis Messenger RNA as a Surrogate for Response to ChemotherapyAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Drug development output from 1975 to 1996: What proportion for tropical diseases?International Journal of Infectious Diseases, 1999
- Community based approaches to the control of multidrug resistant tuberculosis: introducing “DOTS-plus”BMJ, 1998
- Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequenceNature, 1998
- RifapentineDrugs, 1998
- Treatment of Multidrug-Resistant TuberculosisNew England Journal of Medicine, 1993
- Critical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under the district tuberculosis programmeTubercle and Lung Disease, 1993
- Impact of BCG vaccination programmes in children and young adults on the tuberculosis problemTubercle, 1976